| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/15/2006 | US20060128974 Cyclometallated complexes of a group 9 or 10 element prepared from an iminated thiophenecarboxaldehyde and a monoanionic beta-diketone ligand or a monoanionic bidentate chelate ligand having a carboxyl group or a phenolic hydroxyl group; used in devices that operate at low voltage with high efficiency |
| 06/15/2006 | US20060128973 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes |
| 06/15/2006 | US20060128972 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 06/15/2006 | US20060128971 Process for the preparation of the amorphous form of atorvastatin calcium salt |
| 06/15/2006 | US20060128970 3-Pyrrolidin-2-yl-propionic acid derivatives |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128948 obtained by modifying carboxyl groups of biological low-molecular-weight compounds having two or more carboxyl groups with N-hydroxysuccinimide, N-hydroxysulfosuccinimide; used to treat medical devices and the like are non-natural, artificially synthesized products; low toxicity and easily assimilated |
| 06/15/2006 | US20060128789 Especially 4-(hydroxymethyl)pyrrolidin-3-ol, forming camphor sultam from camphorsulfonic acid, SO2Cl2 and NH3 or forming diethyl 2-(benzyloxymethoxy)-3-(benzyloxymethyl)succinate from diethyl maleate and benzyl chloromethyl ether as an intermediate |
| 06/15/2006 | US20060128779 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives |
| 06/15/2006 | US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/15/2006 | US20060128632 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 06/15/2006 | US20060124017 New compounds, a process for their preparation and their use as dyes and pigments |
| 06/15/2006 | CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | CA2587318A1 Pyrrolidin-2-one derivatives for use as dp1 receptor agonists |
| 06/14/2006 | EP1669435A1 Dispersant reaction product with antioxidant capability |
| 06/14/2006 | EP1667967A1 Process for preparing 2-oxo-1-pyrrolidine derivatives |
| 06/14/2006 | EP1667966A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667675A1 Entry inhibitors of the hiv virus |
| 06/14/2006 | EP1667647A2 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1620495A4 Imide-linked maleimide and polymaleimide compounds |
| 06/14/2006 | EP1427702B1 Method for the production of 2-pyrrolidone |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1787817A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/14/2006 | CN1785974A (4S)-1-tert butoxy carbonyl-4-amino-L-ethyl prolinate and its synthesis technology |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | USRE39128 Antibacteria drug; respiratory system disorders; otitis |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060719 Glutaminyl based DPIV inhibitors |
| 06/13/2006 | US7060697 Immunosuppressant compounds and compositions |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006060225A2 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
| 06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 06/08/2006 | WO2005052016B1 Bottom antireflective coatings |
| 06/08/2006 | US20060122404 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of-alpha-perfluoroalkylamines |
| 06/08/2006 | US20060122403 Atorvastatin calcium form vi or hydrates thereof |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122255 Derivatives of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide; for preparation of drugs |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122235 Amine oxidase inhibitor; use in treating Alzheimer's disease; for example, (RS)-1-[6-(4-fluoro-benzyloxy)-pyridin-3-yl]-5-oxo-pyrrolidine-3-carboxylic acid methylamide |
| 06/08/2006 | US20060122230 1,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators |
| 06/08/2006 | US20060122182 Bioassay of testing the compound on the biological system or sample; antihistamines; bronchodilator agents, anticholinergic agents; respiratory system disorders; 2-{(S)-1-[5-(2-methylamino)acetylamino)pentyl]pyrrolidin-3-yl}-2,2-diphenylacetamide |
| 06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 06/08/2006 | US20060122124 Therapeutic agent |
| 06/08/2006 | US20060122100 Melanin extinguisher |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/08/2006 | US20060120959 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
| 06/08/2006 | US20060117497 Azo dye for hair; thickener is anionic amphiphilic polymer |
| 06/07/2006 | EP1666466A2 Mutilin derivatives and their use as Antimicrobials |
| 06/07/2006 | EP1666461A2 Polyaspartimides useful as reactive components for polyisocyanates in two-component polyurethane coating compositions |
| 06/07/2006 | EP1666460A1 Preventive for cerebral stroke recurrence |
| 06/07/2006 | EP1666459A2 Aminocyclohexyl ether compounds and uses thereof |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1664323A1 Enzymatic synthesis of enatiopure intermediates by means of cholesterolesterase from yeasts |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664084A1 Process for the manufacture of an enantiopure compound |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663969A1 Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
| 06/07/2006 | EP1663968A1 Process for the preparation of pure levetiracetam |
| 06/07/2006 | EP1663967A1 PROCESS FOR CONVERTING a-ANGELICA LACTONE TO 5-METHYL-N-ALKYL -2-PYRROLIDONE USING ALKYL AMINES |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1369416B1 Stable crystals of pyrrole compound |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1280847B1 Oligo/polysuccinimides, process for producing thereof and their use |
| 06/07/2006 | CN1784457A Imide-linked maleimide and polymaleimide compounds |
| 06/07/2006 | CN1784381A Method for crystallizing guanidinium salts |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1258532C Compound of poly-amide macrocyclic polyamine and its preparation process and application |
| 06/07/2006 | CN1258528C Method for the production of 2-pyrrolidone |
| 06/07/2006 | CN1258362C Use of substituted acryloyl stallimycin derivatives in treatment of tumors associated with high levels of glutathione |
| 06/06/2006 | US7057053 for treatment of arrhythmia and the production of analgesia and local anesthesia |
| 06/06/2006 | US7057036 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 06/06/2006 | US7057035 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056907 Mandelic acid derivatives and their use as thrombin inhibitors |
| 06/06/2006 | CA2232913C Process for the preparation of azide derivatives |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006056884A1 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors |
| 06/01/2006 | WO2006056752A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 06/01/2006 | WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 06/01/2006 | WO2006056282A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives |
| 06/01/2006 | WO2006056281A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 06/01/2006 | WO2006056166A2 Method for the addition of amides ureas lactams and carbamates to alkynes |
| 06/01/2006 | WO2005118537A3 Arylpiperazine derivatives as adrenergic receptor antagonists |
| 06/01/2006 | WO2005034940A8 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |